EMVision Medical Devices Ltd (ASX:EMV)

Market Cap	147.09M
Revenue (ttm)	8.06M
Net Income (ttm)	-6.19M
Shares Out	85.52M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,636
Average Volume	24,407
Open	1.725
Previous Close	1.750
Day's Range	1.720 - 1.765
52-Week Range	1.630 - 2.350
Beta	0.84
RSI	42.33
Earnings Date	Aug 28, 2025

About EMVision Medical Devices

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. The company offers non-invasive brain scanners bedside device emu, an ultra-light weight first responder pre-hospital device. EMVision Medical Devices Ltd was incorporated in 2017 and is based in Macquarie Park, Australia.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EMV

Financial Performance

In 2024, EMVision Medical Devices's revenue was 11.22 million, an increase of 60.89% compared to the previous year's 6.97 million. Losses were -2.73 million, -29.48% less than in 2023.